Safety Communications > Use of LARIAT Suture Delivery Device for Left Atrial Appendage Closure: FDA Safety Communication

Safety Communications > Use of LARIAT Suture Delivery Device for Left Atrial Appendage Closure: FDA Safety Communication





An FDA Safety Communication has been posted titled, "Use of LARIAT Suture Delivery Device for Left Atrial Appendage Closure."  The FDA is alerting health care providers and patients of reports of patient deaths and other serious adverse events associated with the use of the LARIAT Suture Delivery Device and its associated devices to close the left atrial appendage, a pouch-like region of the left atrium in the heart, in patients with irregular heart rhythm (atrial fibrillation) to prevent stroke.  For more information, please see: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454501.htm